Cancer deaths resulted in more than 4 million potential years of life lost in 2017

November 13, 2020

Bottom Line: Deaths from cancer accounted for more than 4 million potential years of life lost in 2017. While the cancer types with the highest death rates per capita accounted for the greatest number of years lost, cancers that typically occur at younger ages bore a disproportionate share of the burden.

Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research

Author: Minkyo Song, MD, PhD, a research fellow at the National Cancer institute, part of the National Institutes of Health.

Background: "Potential years of life lost (PYLL) is an estimate of the average years a person would have lived if he or she had not died prematurely. Given that cancer is the leading cause of death in those younger than 80 years old, it is important to study the effect of cancer death rates among younger people," Song explained.

In 2017, there were 599,099 cancer deaths in the United States, according to death certificate data from the National Center for Health Statistics.

How the Study was Conducted: Song and colleagues used national mortality data from the U.S. National Center for Health Statistics, coupled with a commonly used definition of PYLL as the number of years lost prior to age 75, to quantify how many years of life were prematurely lost.

Results: The researchers calculated that 4,280,128 years of life were prematurely lost due to cancer in 2017.

For the most part, PYLL mirrored overall U.S. cancer mortality trends. For example, lung cancer, the cancer type that causes the largest number of deaths, accounted for approximately 24.3 percent of U.S. cancer deaths and 20.8 percent of PYLL. Colon/rectum cancer accounted for 8.8 percent of deaths and 9.6 percent of PYLL. Pancreatic cancer accounted for 7.3 percent of deaths and 6.6 percent of PYLL, while breast cancer accounted for 7.1 percent of deaths and 9.4 percent of PYLL.

One exception to this pattern was prostate cancer, which causes about 5.1 percent of U.S. cancer deaths but only 2 percent of PYLL. "Many of the deaths caused by this cancer occurred at older ages, resulting in fewer PYLL," Song noted.

Another metric, PYLL per death, provided a useful tool to measure the burden from several rare cancers that typically affect younger people, Song said. For example, testicular cancer accounted for 0.1 percent of cancer deaths in 2017, and 0.3 percent of PYLL. Bone cancer accounted for 0.3 percent of deaths, but 0.7 percent of PYLL. Although these cancers did not contribute dramatically to overall cancer mortality, they caused the highest numbers of life years lost per death: Testicular cancer had the highest PYLL per death, with an average of 34 years lost, followed by bone cancer, with an average of 26.4 years lost, and endocrine cancers including thymus cancer, with an average of 25.2 years lost.

The total number of PYLL increased slightly from 1990, despite an overall decrease in cancer deaths. In 1990, there were 4,262,397 PYLL, compared with the 4,280,128 recorded in 2017. During this time, overall cancer mortality dropped from 214.9 per 100,000 in 1990 to 152.7 per 100,000 in 2017. The researchers found that the increase in PYLL was due to the growth of the U.S. population.

The study also showed that ethnic and racial minority groups account for a disproportionate share of the burden of premature cancer death. In 2017, 78 percent of all cancer deaths occurred in non-Hispanic whites, but only 70 percent of PYLL occurred in this group. By contrast, Hispanics accounted for 7 percent of cancer deaths and 10 percent of PYLL, while Blacks accounted for 12 percent of cancer deaths and 15 percent of PYLL.

Author's Comments: Overall, Song said, "PYLL is a useful 'complementary measure' to cancer mortality rates. Together, they provide a more detailed picture of the social and economic toll of cancer. PYLL can be used to estimate the impact of cancer death in younger populations. This metric highlights the enormous loss of life due to certain cancers that occur at younger ages, even if they occur infrequently."

Study Limitations: As a limitation, the researchers noted that the study relied on the cause of death reported on death certificates, which are subject to error. They also pointed out that other studies have used different definitions of PYLL, contributing to some differences across the body of research on this topic.

Funding & Disclosures: This study was funded by the Intramural Research Program at the National Cancer Institute. Song declares no conflicts of interest.
About the American Association for Cancer Research

Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes 47,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 127 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops--the largest of which is the AACR Annual Meeting, with more than 100,000 attendees for the 2020 virtual meetings and more than 22,500 attendees for past in-person meetings. In addition, the AACR publishes nine prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to